Corbus Pharmaceuticals Holdings Board of Directors, Key People and Executives

Health Care & Life Sciences » Biotechnology | Corbus Pharmaceuticals Holdings Inc.

Corbus Pharmaceuticals Holdings Inc. | Key People and Executives

Yuval Cohen

Chief Executive Officer & Director

John Kenneth Jenkins

Director

David P. Hochman

Director

Alan F. Holmer

Chairman

Paris Panayiotopoulos

Independent Director

Avery W. Catlin

Independent Director

Mark A. Tepper

President & Chief Scientific Officer

Yuval Cohen

Chief Executive Officer & Director

Sean F. Moran

CFO & Principal Accounting Officer

Barbara White

Chief Medical Officer

Robert Discordia

VP-Pharmaceutical Development & Manufacturing

John Kenneth Jenkins

Director

David P. Hochman

Director

Ross Lobell

Vice President-Regulatory Affairs

Alan F. Holmer

Chairman

Paris Panayiotopoulos

Independent Director

Avery W. Catlin

Independent Director

View Profile

Address	500 River Ridge Drive Norwood Massachusetts 02062 United States
Employees	-
Website	http://www.corbuspharma.com
Updated	07/08/2019
Corbus Pharmaceuticals Holdings, Inc. is a phase 3 clinical-stage pharmaceutical company, focused on the development and commercialization of novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases. The Company's lead product candidate, lenabasum, is a novel, synthetic oral endocannabinoid-mimetic drug designed to resolve chronic inflammation and fibrotic processes. Lenabasum is currently being evaluated in systemic sclerosis, cystic fibrosis, dermatomyositis, and systemic lupus erythematosus.